World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
44
Citations
9003
World Ranking
19241
National Ranking
7864

Overview

Mark A. Winters is affiliated with Stanford University in the United States. Their research primarily centers around the field of Medicine, with specific contributions to several subfields including Infectious Diseases, Virology, Genetics, Surgery, and Pediatrics, Perinatology and Child Health.

The scientist's work covers a range of main topics, notably:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • Animal Genetics and Reproduction
  • Hemodynamic Monitoring and Therapy
  • Childhood Cancer Survivors' Quality of Life
  • Adolescent and Pediatric Healthcare
  • Cancer survivorship and care

Mark A. Winters has authored several recent papers, including:

  • "HIV-1 Protease, Reverse Transcriptase, and Integrase Variation," 2020, UNC Libraries
  • "481 Studying Resuscitation Resource Utilization for Isolated Hypotension," 2025, Annals of Emergency Medicine
  • "Work Status, Absenteeism, Presenteeism, and Quality of Life in Young Adult Cancer Survivors," 2025, JAMA Network Open

Frequent co-authors collaborating with Winters include:

  • Soo-Yon Rhee
  • Kris Sankaran
  • Vici Varghese
  • Christopher B. Hurt
  • Joseph J. Eron

Mark A. Winters' publications often appear in these venues:

  • UNC Libraries
  • Annals of Emergency Medicine
  • JAMA Network Open

Best Publications

  • A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy

    John D. Baxter;Douglas L. Mayers;Deborah N. Wentworth;James D. Neaton

  • siRNA Delivery into Human T Cells and Primary Cells with Carbon‐Nanotube Transporters

    Zhuang Liu;Mark Winters;Mark Holodniy;Hongjie Dai

  • Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

    Ronald T. Mitsuyasu;Thomas C. Merigan;Andrew D Carr;Jerome A. Zack

  • The Effect of High-Dose Saquinavir on Viral Load and CD4+ T-Cell Counts in HIV-Infected Patients

    Jonathan M. Schapiro;Mark A. Winters;Fran Stewart;Bradley Efron

  • Frequency of Class I HLA-Restricted Anti-HIV CD8+ T Cells in Individuals Receiving Highly Active Antiretroviral Therapy (HAART)

    Clive M. Gray;Jody Lawrence;Jonathan M. Schapiro;John D. Altman;John D. Altman

  • Multidrug-Resistant Human Immunodeficiency Virus Type 1 Strains Resulting from Combination Antiretroviral Therapy

    Astrid K N Iversen;Robert W. Shafer;Kathy Wehrly;Mark A. Winters

  • Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.

    Christopher Koh;Laetitia Canini;Laetitia Canini;Harel Dahari;Harel Dahari;Xiongce Zhao

  • Patient compliance and drug failure in protease inhibitor monotherapy.

    Geertrui F. Vanhove;Jonathan M. Schapiro;Mark A. Winters;Thomas C. Merigan

  • A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors.

    M A Winters;K L Coolley;Y A Girard;D J Levee

  • Multiple Concurrent Reverse Transcriptase and Protease Mutations and Multidrug Resistance of HIV-1 Isolates from Heavily Treated Patients

    Robert W. Shafer;Mark A. Winters;Sarah Palmer;Thomas C. Merigan

  • A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution.

    Robert J. Gifford;Aris Katzourakis;Michael Tristem;Oliver G. Pybus

  • Combination Therapy with Zidovudine and Didanosine Selects for Drug-Resistant Human Immunodeficiency Virus Type 1 Strains with Unique Patterns of pol Gene Mutations

    Robert W. Shafer;Michael J. Kozal;Mark A. Winters;Astrid K.N. Iversen

  • Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years.

    M. A. Winters;R. W. Shafer;R. A. Jellinger;G. Mamtora

  • Ultrasensitive detection of rare mutations using next-generation targeted resequencing

    Patrick Flaherty;Georges Natsoulis;Omkar Muralidharan;Mark Winters

  • Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.

    Thomas B. Campbell;Laura M. Smeaton;N. Kumarasamy;Timothy Flanigan

  • Multicenter Evaluation Of Quantification Methods For Plasma Human Immunodeficiency Virus Type 1 Rna

    Hsiang Ju Lin;Lawrence E. Myers;Belinda Yen-Lieberman;F. Blaine Hollinger

  • A Mutation in Human Immunodeficiency Virus Reverse Transcriptase and Decline in CD4 Lymphocyte Numbers in Long-Term Zidovudine Recipients

    Michael J. Kozal;Robert W. Shafer;Mark A. Winters;David A. Katzenstein

  • The Genes Encoding the gCIII Complex of Human Cytomegalovirus Exist in Highly Diverse Combinations in Clinical Isolates

    Lucy Rasmussen;Aimee Geissler;Catherine Cowan;Amanda Chase

  • Human Immunodeficiency Virus Type 1 Protease Genotypes and In Vitro Protease Inhibitor Susceptibilities of Isolates from Individuals Who Were Switched to Other Protease Inhibitors after Long-Term Saquinavir Treatment

    Mark A. Winters;Jonathan M. Schapiro;Jody Lawrence;Thomas C. Merigan

  • Inter- and Intragenic Variations Complicate the Molecular Epidemiology of Human Cytomegalovirus

    Lucy Rasmussen;Aimee Geissler;Mark Winters

Frequent Co-Authors

Mark Holodniy
Mark Holodniy Stanford University
Thomas C. Merigan
Thomas C. Merigan Stanford University
Robert W. Shafer
Robert W. Shafer Stanford University
David Katzenstein
David Katzenstein Stanford University
Jeffrey S. Glenn
Jeffrey S. Glenn Stanford University
Jonathan M. Schapiro
Jonathan M. Schapiro Sheba Medical Center
Theo Heller
Theo Heller National Institutes of Health
Soo-Yon Rhee
Soo-Yon Rhee Stanford University
David E. Kleiner
David E. Kleiner National Institutes of Health
Robert W. Coombs
Robert W. Coombs University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Biology and Biochemistry in the USA unlocks a diverse range of further educational and career options, especially through online learning. Many students build on their foundation by exploring specialized degrees that align with healthcare, research, or management roles.

One fast-paced route is to consider a fast online master's in healthcare management, which prepares graduates for administrative and leadership positions in medical and scientific organizations. If you’re more interested in mental health, a psychiatric np programs track can lead to becoming a specialized nurse practitioner.

For those fascinated by wellness and diet, an online holistic nutrition degree equips students to guide clients toward healthier lifestyles. Alternatively, an affordable online mba in healthcare management strengthens business acumen in the thriving healthcare sector.

These online pathways offer flexibility and practical skills, helping biology and biochemistry graduates progress confidently toward their desired careers.

Best Scientists Citing Mark A. Winters

Trending Scientists